Hargreave Hale AIM VCT Valuation Multiples
Discover Hargreave Hale AIM VCT's revenue and EBITDA valuation multiples and investment history.
Hargreave Hale AIM VCT Overview
About Hargreave Hale AIM VCT
Hargreave Hale AIM VCT PLC is active in the United Kingdom. The investment objectives of the Company are to generate capital gains and income from its portfolio and to make distributions from capital or income to shareholders while maintaining its status as a Venture Capital Trust. The Company has one operating segment, which is investment in equity and debt securities. The investment portfolio includes Information Technology, Health Care, Consumer Discretionary, Industrials, Communication Services, Financial Services, Materials, Real Estate, and Utilities.
Founded
2004
HQ
Employees
0
Website
Financials (FY)
EV
$154M
Valuation Multiples
Start free trial
Hargreave Hale AIM VCT Financials
Hargreave Hale AIM VCT reported last fiscal year revenue of $818K.
In the same fiscal year, Hargreave Hale AIM VCT generated had net loss of ($697K).
Hargreave Hale AIM VCT P&L
In the most recent fiscal year, Hargreave Hale AIM VCT reported revenue of $818K and net income of ($697K).
Hargreave Hale AIM VCT is unprofitable as of last fiscal year, with net margin of (85%).
Financial data powered by Morningstar, Inc.
Hargreave Hale AIM VCT Stock Performance
Hargreave Hale AIM VCT has current market cap of $154M, and enterprise value of $154M.
Hargreave Hale AIM VCT's stock price is $0.41.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $154M | $154M | 0.0% | - | - | - | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHargreave Hale AIM VCT Valuation Multiples
Hargreave Hale AIM VCT trades at 188.4x EV/Revenue multiple.
Hargreave Hale AIM VCT Financial Valuation Multiples
As of August 3, 2026, Hargreave Hale AIM VCT has market cap of $154M and EV of $154M.
Hargreave Hale AIM VCT has a P/E ratio of (221.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hargreave Hale AIM VCT Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Hargreave Hale AIM VCT Margins & Growth Rates
In the most recent fiscal year, Hargreave Hale AIM VCT reported net margin of (85%).
Hargreave Hale AIM VCT Margins
Hargreave Hale AIM VCT Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Hargreave Hale AIM VCT Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Hargreave Hale AIM VCT Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Hargreave Hale AIM VCT competitors and their valuation data. Start Free Trial | ||||||
Investments by Hargreave Hale AIM VCT
Hargreave Hale AIM VCT has invested in 3 companies to date.
Latest investment by Hargreave Hale AIM VCT was on July 28th 2026. Hargreave Hale AIM VCT invested in Qureight in their $20M Series B round (EV/Revenue multiple available to Pro users).
Latest Investments by Hargreave Hale AIM VCT
| Description | Qureight is an imaging analytics company applying AI to thoracic diseases like idiopathic pulmonary fibrosis and lung cancer. Its LungQ platform quantifies CT scans for fibrosis extent, cancer nodules, and emphysema severity, aiding clinical trials and diagnostics. London-based Qureight collaborates with AstraZeneca and Boehringer Ingelheim. | Qureight is an imaging analytics company applying AI to thoracic diseases like idiopathic pulmonary fibrosis and lung cancer. Its LungQ platform quantifies CT scans for fibrosis extent, cancer nodules, and emphysema severity, aiding clinical trials and diagnostics. London-based Qureight collaborates with AstraZeneca and Boehringer Ingelheim. | AirPortr is a London-headquartered baggage technology provider operating at 20 airports including Heathrow and JFK since 2016. Its app-based system allows early bag drop at hotels or city centers, reducing terminal queues and landside operations for airlines like British Airways. The service handles 1 million bags yearly, integrating with airline check-in for seamless tracking. | HonestBrew is a London-based online retailer specializing in craft beers from independent breweries worldwide. It curates selections from microbreweries in the UK, US, Europe, and beyond, delivering to customers across the United Kingdom. Established during the UK craft beer boom, HonestBrew stocks over 1,000 beers including IPAs, stouts, and sours from producers like BrewDog, Magic Rock, and Cloudwater. The platform offers subscription boxes, tasting kits, and temperature-controlled shipping to preserve quality. HonestBrew holds a strong position in the growing UK craft beer market valued at over £2 billion annually. |
| HQ Country |  | | | |
| HQ City | Cambridge | Cambridge | London | London |
| Deal Date | 28 Jul 2026 | 16 Apr 2024 | 16 Aug 2019 | 1 Aug 2017 |
| Round | Series B | Series A | Series A | Seed |
| Raised | $20M | $9M | $9M | $2M |
| Investors | Guinness VCT; Meltwind Advisory; Molten Ventures; XTX Ventures; Hargreave Hale AIM VCT; Ascension | Guinness VCT; Ascension Life Fund; Meltwind Advisory; Playfair Capital; XTX Ventures; Hargreave Hale AIM VCT; Cambridge Angels group; Nexenai Capital | Force Over Mass Capital; Esken; Hargreave Hale AIM VCT; JamJar Investments; Vela Technologies | Hargreave Hale AIM VCT |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Hargreave Hale AIM VCT investments and their VC round multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hargreave Hale AIM VCT
| When was Hargreave Hale AIM VCT founded? | Hargreave Hale AIM VCT was founded in 2004. |
| Where is Hargreave Hale AIM VCT headquartered? | Hargreave Hale AIM VCT is headquartered in United Kingdom. |
| How many employees does Hargreave Hale AIM VCT have? | As of today, Hargreave Hale AIM VCT has over 0 employees. |
| Is Hargreave Hale AIM VCT publicly listed? | Yes, Hargreave Hale AIM VCT is a public company listed on London Stock Exchange. |
| What is the stock symbol of Hargreave Hale AIM VCT? | Hargreave Hale AIM VCT trades under HHV ticker. |
| Who are competitors of Hargreave Hale AIM VCT? | Hargreave Hale AIM VCT main competitors include |
| What is the current market cap of Hargreave Hale AIM VCT? | Hargreave Hale AIM VCT's current market cap is $154M. |
| What is the current revenue of Hargreave Hale AIM VCT? | Hargreave Hale AIM VCT's last fiscal year revenue is $818K. |
| What is the current EV/Revenue multiple of Hargreave Hale AIM VCT? | Current revenue multiple of Hargreave Hale AIM VCT is 188.4x. |
| Is Hargreave Hale AIM VCT profitable? | No, Hargreave Hale AIM VCT is not profitable. |
| How many companies Hargreave Hale AIM VCT has acquired to date? | Hargreave Hale AIM VCT hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Hargreave Hale AIM VCT has invested to date? | As of August 2026, Hargreave Hale AIM VCT has invested in 3 companies. |
| What was the last Hargreave Hale AIM VCT investment? | On 28th July 2026 Hargreave Hale AIM VCT invested in Qureight, participating in a $20M Series B round, alongside Guinness VCT, Meltwind Advisory, Molten Ventures, XTX Ventures, and Ascension. |
| In what companies Hargreave Hale AIM VCT invested in? | Hargreave Hale AIM VCT invested in Qureight, AirPortr, and HonestBrew. |
Lists including Hargreave Hale AIM VCT
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.